Yukino Sato

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yasumitsu Nishimura, Kenta Nomiyama, Shuichiro Okamoto, Mika Igarashi, Yusuke Yorifuji, Yukino Sato, Ayasa Kamezaki, Aya Morihara, Futoshi Kuribayashi, Akira Yamauchi
Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2. PloS one 17 (12) (2022)
Yasumitsu Nishimura, Kenta Nomiyama, Shuichiro Okamoto, Mika Igarashi, Yusuke Yorifuji, Yukino Sato, Ayasa Kamezaki, Aya Morihara, Futoshi Kuribayashi, Akira Yamauchi
Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2. PloS one 17 (12) (2022)
Yasumitsu Nishimura, Kenta Nomiyama, Shuichiro Okamoto, Mika Igarashi, Yusuke Yorifuji, Yukino Sato, Ayasa Kamezaki, Aya Morihara, Futoshi Kuribayashi, Akira Yamauchi
Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2. PloS one 17 (12) (2022)
Yasumitsu Nishimura, Kenta Nomiyama, Shuichiro Okamoto, Mika Igarashi, Yusuke Yorifuji, Yukino Sato, Ayasa Kamezaki, Aya Morihara, Futoshi Kuribayashi, Akira Yamauchi
Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2. PloS one 17 (12) (2022)
Yasumitsu Nishimura, Kenta Nomiyama, Shuichiro Okamoto, Mika Igarashi, Yusuke Yorifuji, Yukino Sato, Ayasa Kamezaki, Aya Morihara, Futoshi Kuribayashi, Akira Yamauchi
Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2. PloS one 17 (12) (2022)
Yasumitsu Nishimura, Kenta Nomiyama, Shuichiro Okamoto, Mika Igarashi, Yusuke Yorifuji, Yukino Sato, Ayasa Kamezaki, Aya Morihara, Futoshi Kuribayashi, Akira Yamauchi
Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2. PloS one 17 (12) (2022)